Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.14% | -19.86% | -42.39% | -47.22% | -43.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.14% | -19.86% | -42.39% | -47.22% | -43.31% |
| Cost of Revenue | -19.25% | -23.14% | -40.31% | -40.95% | -29.57% |
| Gross Profit | 4.30% | -17.91% | -43.59% | -50.50% | -49.85% |
| SG&A Expenses | -14.26% | -21.02% | -25.72% | -26.34% | -18.80% |
| Depreciation & Amortization | 14.05% | -1.25% | -1.87% | -1.73% | -2.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.96% | -19.93% | -28.01% | -28.64% | -20.59% |
| Operating Income | 25.19% | 20.01% | -18.13% | -51.92% | -114.84% |
| Income Before Tax | 17.81% | 17.32% | -23.72% | -35.07% | -108.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.81% | 17.32% | -23.72% | -35.07% | -108.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.81% | 17.32% | -23.72% | -35.07% | -108.25% |
| EBIT | 25.19% | 20.01% | -18.13% | -51.92% | -114.84% |
| EBITDA | 27.62% | 16.84% | -36.76% | -85.84% | -205.70% |
| EPS Basic | 18.97% | 16.95% | -23.81% | -35.90% | -107.14% |
| Normalized Basic EPS | 16.67% | 16.22% | -22.22% | -32.00% | -100.00% |
| EPS Diluted | 18.97% | 16.95% | -23.81% | -35.90% | -107.14% |
| Normalized Diluted EPS | 16.67% | 16.22% | -22.22% | -32.00% | -100.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |